Pharmaceutical

CPC Launches Industry-First Product for Cell and Gene Therapy Sterile Processing

DOWNERS GROVE, Ill., Jan. 29, 2025 /PRNewswire/ -- CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer…

11 months ago

Image Analysis Group Announces Release of DYNAMIKA V.7, their Award-Winning Cloud Platform for Clinical Trial Imaging

DYNAMIKA V.7 has achieved the British Standards Institute (BSI) surveillance audit certification following a recent SOC II Type I compliance…

11 months ago

TraceLink Named a Top 10 Pharma and Life Sciences Technology Solution Provider by CIOTechOutlook

BOSTON, Jan. 29, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain,…

11 months ago

ArisGlobal Announces Significant Customer Growth and Unprecedented Product Innovations in 2024

11 net new LifeSphere customers, 57 customer go-lives, and expanded adoption of NavaX BOSTON, Jan. 29, 2025 /PRNewswire/ -- ArisGlobal, an…

11 months ago

Medrio’s Launches AI-Enabled Reporting, Tackling Increasing Data Challenges in Clinical Trials

SAN FRANCISCO, Jan. 29, 2025 /PRNewswire/ -- Medrio, a global leader in clinical trial technology, today announced the release of AI-enabled…

11 months ago

Princeton Biopartners Welcomes Dr. Synøve Kamøy as Engagement Manager

NEW YORK, Jan. 29, 2025 /PRNewswire/ -- Princeton Biopartners, a best-in-class provider of integrated consulting solutions to the life sciences sector,…

11 months ago

Precision AQ Launches Navigator365™ Matrix, an Advanced Platform for Identifying Digital Opinion Leaders to Activate and Amplify Brand Messages

The latest addition to the Navigator365™ Omnichannel product family transforms how life sciences companies engage with digital influencers through actionable insights…

11 months ago

More Than 200 Companies Advance Trial Management with Veeva CTMS

Biopharmas use leading CTMS for improved trial efficiency and collaboration PLEASANTON, Calif., Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE:…

11 months ago

Adial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Completion enables the End-of-Phase 2 (EOP2) interaction with the FDA on the design of the Phase 3 program and is…

11 months ago

Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress

Carlsbad, CA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical…

11 months ago